Jacqueline is the Chief Clinical Officer and a board Director of the Cell and Gene Therapy Catapult, the UK’s centre for the acceleration of the translation of cell therapies towards commercialization. Her groups include experts in Regulatory Affairs, Nonclinical testing, Clinical Operations and Development, including the roll out of Cell and Gene Therapies in a healthcare setting. Prior to this Jacqueline worked at the Scottish National Blood Transfusion Service where amongst other activities she designed the regulatory strategy for the Cellular Therapies for the Blood Transfusion Service and acted as Qualified Person for their release. Before that she held a number of post-Doctoral academic posts at the University of Edinburgh studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell based medicinal products and therapies.